A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection.
Singla A, Dadario NB, Singla A, Greenberg P, Yan R, Nanda A, Boison D, Malhotra R, Patel S, Nipun S, Maninderpal K, Castro D, Bdiiwi S, Boktor H, Kyi HH, Sutherland A, Patrawalla A, Ly K, Xie Y, Sonig A, Khandelwal P, Liu J, Koziol J, Finkle D, Subanna S, Libutti SK.
Singla A, et al. Among authors: boison d.
PLoS One. 2023 Jan 30;18(1):e0274243. doi: 10.1371/journal.pone.0274243. eCollection 2023.
PLoS One. 2023.
PMID: 36716303
Free PMC article.
Clinical Trial.